References
- Judd L.M., Gleeson P.A., Toh B.H., van Driel I.R. Autoimmune gastritis results in disruption of gastric epithelial cell development. Am. J. Physiol. 1999; 277: G209–G218, [PUBMED], [INFOTRIEVE]
- Canfield V., West A.B., Goldenring J.R., Levenson R. Genetic ablation of parietal cells in transgenic mice: a new model for analyzing cell lineage relationships in the gastric mucosa. Proc. Natl. Acad. Sci. USA 1996; 93: 2431–2435, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Li Q., Karam S.M., Gordon J.I. Diphtheria toxin-mediated ablation of parietal cells in the stomach of transgenic mice. J. Biol. Chem. 1996; 271: 3671–3676, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bockman D.E., Sharp R., Merlino G. Regulation of terminal differentiation of zymogenic cells by transforming growth factor alpha in transgenic mice. Gastroenterology 1995; 108: 447–454, [PUBMED], [INFOTRIEVE]
- Sharp R., Babyatsky M.W., Takagi H., Tagerud S., Wang T.C., Bockman D.E., Brand S.J., Merlino G. Transforming growth factor alpha disrupts the normal program of cellular differentiation in the gastric mucosa of transgenic mice. Development 1995; 121: 149–161, [PUBMED], [INFOTRIEVE]
- Li Q., Karam S.M., Coerver K.A., Matzuk M.M., Gordon J.I. Stimulation of activin receptor II signaling pathways inhibits differentiation of multiple gastric epithelial lineages. Mol. Endocrinol. 1998; 12: 181–192, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Marshall A.C., Alderuccio F., Toh B.H. Fas/CD95 is required for gastric mucosal damage in autoimmune gastritis. Gastroenterology 2002; 123: 780–789, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nishio A., Katakai T., Oshima C., Kasakura S., Sakai M., Yonehara S., Suda T., Nagata S., Masuda T. A possible involvement of Fas-Fas ligand signaling in the pathogenesis of murine autoimmune gastritis. Gastroenterology 1996; 111: 959–967, [PUBMED], [INFOTRIEVE]
- De Maria R., Testi R. Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity. Immunol. Today 1998; 19: 121–125, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Zumsteg U., Frigerio S., Hollander G.A. Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine beta-cell damage. Diabetes 2000; 49: 39–47, [PUBMED], [INFOTRIEVE]
- Fiorucci S., Santucci L., Antonelli E., Distrutti E., Del Sero G., Morelli O., Romani L., Federici B., Del Soldato P., Morelli A. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology 2000; 118: 404–421, [PUBMED], [INFOTRIEVE]
- D'Elios M.M., Bergman M.P., Azzurri A., Amedei A., Benagiano M., De Pont J.J., Cianchi F., Vandenbroucke-Grauls C.M., Romagnani S., Appelmelk B.J., Del Prete G. H(+), K(+)-ATPase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology 2001; 120: 377–386, [PUBMED], [INFOTRIEVE]
- Mixter P.F., Russell J.Q., Durie F.H., Budd R.C. Decreased CD4-CD8- TCR-alpha beta + cells in lpr/lpr mice lacking beta 2-microglobulin. J. Immunol. 1995; 154: 2063–2074, [PUBMED], [INFOTRIEVE]
- Budd R.C., Mixter P.F. The origin of CD4-CD8-TCR alpha beta+ thymocytes: a model based on T-cell receptor avidity. Immunol. Today 1995; 16: 428–431, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shirai T., Abe M., Yagita H., Okumura K., Morse H.C.D., Davidson W.F. The expanded populations of CD4-CD8- T cell receptor alpha/beta+ T cells associated with the lpr and gld mutations are CD2. J. Immunol. 1990; 144: 3756–3761, [PUBMED], [INFOTRIEVE]
- Cohen P.L., Eisenberg R.A. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Ann. Rev. Immunol. 1991; 9: 243–269, [CROSSREF]
- Su X., Hu Q., Kristan J.M., Costa C., Shen Y., Gero D., Matis L.A., Wang Y. Significant role for Fas in the pathogenesis of autoimmune diabetes. J. Immunol. 2000; 164: 2523–2532, [PUBMED], [INFOTRIEVE]
- Peschon J.J., Torrance D.S., Stocking K.L., Glaccum M.B., Otten C., Willis C.R., Charrier K., Morrissey P.J., Ware C.B., Mohler K.M. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 1998; 160: 943–952, [PUBMED], [INFOTRIEVE]
- Wallach D., Varfolomeev E.E., Malinin N.L., Goltsev Y.V., Kovalenko A.V., Boldin M.P. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 1999; 17: 331–367, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Marshall A.C., Toh B.H., Alderuccio F. Tumor necrosis factor alpha is not implicated in the genesis of experimental autoimmune gastritis. J. Autoimmun. 2004; 22(1)1–11, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pasparakis M., Alexopoulou L., Episkopou V., Kollias G. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 1996; 184: 1397–1411, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pasparakis M., Kousteni S., Peschon J., Kollias G. Tumor necrosis factor and the p55TNF receptor are required for optimal development of the marginal sinus and for migration of follicular dendritic cell precursors into splenic follicles. Cell Immunol. 2000; 201: 33–41, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Thalmaier U., Lehn N., Pfeffer K., Stolte M., Vieth M., Schneider-Brachert W. Role of tumor necrosis factor alpha in Helicobacter pylori gastritis in tumor necrosis factor receptor 1-deficient mice. Infect. Immunol. 2002; 70: 3149–3155, [CROSSREF]
- Van Ostade X., Vandenabeele P., Tavernier J., Fiers W. Human tumor necrosis factor mutants with preferential binding to and activity on either the R55 or R75 receptor. Eur. J. Biochem. 1994; 220: 771–779, [PUBMED], [INFOTRIEVE]
- Tartaglia L.A., Goeddel D.V. Two TNF receptors. Immunol. Today 1992; 13: 151–153, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Seitz C., Mannel D.N., Hehlgans T. Isolation and functional characterization of the mouse p75 TNF receptor promoter. Genomics 1998; 48: 111–116, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Tartaglia L.A., Rothe M., Hu Y.F., Goeddel D.V. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 1993; 73: 213–216, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Neumann B., Luz A., Pfeffer K., Holzmann B. Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor. J. Exp. Med. 1996; 184: 259–264, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Tartaglia L.A., Pennica D., Goeddel D.V. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 1993; 268: 18542–18548, [PUBMED], [INFOTRIEVE]